Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indonesia Pondasi Raya Tbk. (IDPR) vs Indofarma Tbk. (INAF) Price & Performance

Indonesia Pondasi Raya Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Indonesia Pondasi Raya Tbk. vs Indofarma Tbk. — how do they compare? Indonesia Pondasi Raya Tbk. trades at Rp278 (market cap 540.81B, 680.7K 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indonesia Pondasi Raya Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

IDPRINAF
Market Cap
540.81B390.51B
Volume
680.7K
Lot
6.81K
Turnover
198.43M
Average Price
291.51
Value
198.43M
Indicative Equilibrium Price
286
Indicative Equilibrium Volume
10

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IDPR
View details
INAF
View details

About Indonesia Pondasi Raya Tbk.

PT Indonesia Pondasi Raya Tbk (the Company) was established in Jakarta based on Notarial Deed Tan Thong Kie No. 18 dated 21 October 1977 and has been approved by the Ministry of Law in its decision letter No. Y.A 5/118/24 and was published in Supplement No. 430 of the State Gazette No. 49 dated 17 June 1980.

Read more on IDPR

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF